Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
ZJLD Group HK$5.3 billion IPO
We advised ZJLD on its IPO and HKEX listing
PGE $300 million at-the-market offering
The common stock is listed on the NYSE
IDEAYA Biosciences $201 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Canada $4 billion global bond offering
The investment-grade bonds are due 2028
Morgan Stanley $6 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Bank of America $8.5 billion fixed-to-floating-rate notes
The investment-grade notes are due 2029 and 2034
Pilgrim’s Pride $1 billion notes offering
The investment-grade notes are due 2033
Diagnósticos da América R$1.7 billion equity offering
The common shares and the warrants are listed on the São Paulo Stock Exchange
Gamida Cell $23 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Successful resolution of a media company's deduction for abandoned content
We defended the company against an IRS claim